{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:04:43Z","timestamp":1778893483699,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-023-02910-x","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T20:01:56Z","timestamp":1699560116000},"page":"260-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HMG-CoA reductase inhibitors and the attenuation of risk for disseminated intravascular coagulation in patients with sepsis"],"prefix":"10.1007","volume":"57","author":[{"given":"Nicholas B.","family":"Alana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Ciurylo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Hurlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"key":"2910_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2019.04.025","volume":"178","author":"S Gando","year":"2019","unstructured":"Gando S, Shiraishi A, Yamakawa K et al (2019) Japanese Association for Acute Medicine [JAAM) focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) Study Group. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res 178:182\u2013188. https:\/\/doi.org\/10.1016\/j.thromres.2019.04.025","journal-title":"Thromb Res"},{"key":"2910_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1182\/blood-2017-10-804096","volume":"131","author":"M Levi","year":"2018","unstructured":"Levi M, Scully M (2018) How I treat disseminated intravascular coagulation. Blood 131:845\u2013854. https:\/\/doi.org\/10.1182\/blood-2017-10-804096","journal-title":"Blood"},{"key":"2910_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ams2.411","volume":"7","author":"T Iba","year":"2019","unstructured":"Iba T, Watanabe E, Umemura Y, Wada T, Hayashida K, Kushimoto S (2019) Japanese surviving Sepsis Campaign Guideline Working Group for disseminated intravascular coagulation. Sepsis-associated disseminated intravascular coagulation and its differential diagnoses. J Intensive Care 7:32. https:\/\/doi.org\/10.1002\/ams2.411","journal-title":"J Intensive Care"},{"key":"2910_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40560-016-0149-0","volume":"23","author":"K Okamoto","year":"2016","unstructured":"Okamoto K, Tamura T, Sawatsubashi Y (2016) Sepsis and disseminated intravascular coagulation. J Intensive Care 23:4\u201323. https:\/\/doi.org\/10.1186\/s40560-016-0149-0","journal-title":"J Intensive Care"},{"key":"2910_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/nature01326","author":"J Cohen","year":"2002","unstructured":"Cohen J (2002) The immunopathogenesis of sepsis. Nature. https:\/\/doi.org\/10.1038\/nature01326. 420:885 \u2013 91","journal-title":"Nature"},{"key":"2910_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","volume":"45","author":"JK Liao","year":"2005","unstructured":"Liao JK, Laufs U (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45:89\u2013118. https:\/\/doi.org\/10.1146\/annurev.pharmtox.45.120403.095748","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2910_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1573403X13666170426104611","volume":"13","author":"E Diamantis","year":"2017","unstructured":"Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T (2017) The anti-inflammatory effects of statins on Coronary Artery Disease: an updated review of the literature. Curr Cardiol Rev 13:209\u2013216. https:\/\/doi.org\/10.2174\/1573403X13666170426104611","journal-title":"Curr Cardiol Rev"},{"key":"2910_CR8","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1097\/01.ccm.0000147769.07699.e3","volume":"32","author":"K Bakhtiari","year":"2004","unstructured":"Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416\u20132421. https:\/\/doi.org\/10.1097\/01.ccm.0000147769.07699.e3","journal-title":"Crit Care Med"},{"key":"2910_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA 315:801. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"issue":"6","key":"2910_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/clc.23347","volume":"43","author":"AC Sidebottom","year":"2020","unstructured":"Sidebottom AC, Vacquier MC, Jensen JC et al (2020) Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system. Clin Cardiol 43(6):560\u2013567. https:\/\/doi.org\/10.1002\/clc.23347","journal-title":"Clin Cardiol"},{"key":"2910_CR11","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1182\/blood-2019-132071","volume":"134","author":"AM Roy","year":"2019","unstructured":"Roy AM, Konda M, Goel A, Sasapu A (2019) Epidemiology and factors affecting mortality of hospitalized patients with disseminated intravascular coagulation in the United States. Blood 134:2404. https:\/\/doi.org\/10.1182\/blood-2019-132071","journal-title":"Blood"},{"key":"2910_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A (2013) Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 11:223\u2013233. https:\/\/doi.org\/10.1111\/jth.12075","journal-title":"J Thromb Haemost"},{"key":"2910_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2013","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, Deutschman CS, Escobar GJ, Angus DC (2013) Assessment of Clinical Criteria for Sepsis: for the Third International Consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA 315:762\u2013774. https:\/\/doi.org\/10.1001\/jama.2016.0288","journal-title":"JAMA"},{"key":"2910_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00001721-199909000-00002","volume":"10","author":"M Yamazaki","year":"1999","unstructured":"Yamazaki M, Aoshima K, Mizutani T, Ontachi Y, Saito M, Morishita E, Asakura H, Matsuda T, Triplett DA (1999) Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression. Blood Coagul Fibrinolysis 10:321\u2013330. https:\/\/doi.org\/10.1097\/00001721-199909000-00002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2910_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3892\/etm.2013.1466","volume":"7","author":"XL Liu","year":"2014","unstructured":"Liu XL, Wang XZ, Liu XX, Hao D, Jaladat Y, Lu F, Sun T, Lv CJ (2014) Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study. Exp Ther Med 7:604\u2013608. https:\/\/doi.org\/10.3892\/etm.2013.1466","journal-title":"Exp Ther Med"},{"key":"2910_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0049-3848(93)90109-2","volume":"72","author":"N Sakuragawa","year":"1993","unstructured":"Sakuragawa N, Hasegawa H, Maki M, Nakagawa M, Nakashima M (1993) Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin. Thromb Res 72:475\u2013500. https:\/\/doi.org\/10.1016\/0049-3848(93)90109-2","journal-title":"Thromb Res"},{"key":"2910_CR17","doi-asserted-by":"publisher","first-page":"8S28S","DOI":"10.1177\/1076029618806424","volume":"24","author":"C Papageorgiou","year":"2018","unstructured":"Papageorgiou C, Jourdi G, Adjambri E, Walborn A, Patel P, Fareed J, Elalamy I, Hoppensteadt D, Gerotziafas GT (2018) Disseminated intravascular coagulation: an update on Pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost 24:8S28S. https:\/\/doi.org\/10.1177\/1076029618806424","journal-title":"Clin Appl Thromb Hemost"},{"key":"2910_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1901","author":"MK Jain","year":"2005","unstructured":"Jain MK, Ridker PM (2005) Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/nrd1901. 4:977 \u2013 87","journal-title":"Nat Rev Drug Discov"},{"key":"2910_CR19","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000151647.14923.ec","author":"A Undas","year":"2005","unstructured":"Undas A, Brummel-Ziedins KE, Mann KG (2005) Statins and blood coagulation. Arterioscler Thromb Vasc Biol. https:\/\/doi.org\/10.1161\/01.ATV.0000151647.14923.ec. 25:287 \u2013 94","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","volume":"28","author":"J Greenwood","year":"2007","unstructured":"Greenwood J, Mason JC (2007) Statins and the vascular endothelial inflammatory response. Trends Immunol 28:88\u201398. https:\/\/doi.org\/10.1016\/j.it.2006.12.003","journal-title":"Trends Immunol"},{"key":"2910_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/joim.12296","volume":"276","author":"L Badimon","year":"2014","unstructured":"Badimon L, Vilahur G (2014) Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 276:618\u2013632. https:\/\/doi.org\/10.1111\/joim.12296","journal-title":"J Intern Med"},{"key":"2910_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/hq0801.094222","volume":"21","author":"L Diomede","year":"2001","unstructured":"Diomede L, Albani D, Sottocorno M, Donati MB, Bianchi M, Fruscella P, Salmona M (2001) In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 21:1327\u20131332. https:\/\/doi.org\/10.1161\/hq0801.094222","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1161\/01.atv.0000030360.72503.56","volume":"22","author":"GK Sukhova","year":"2002","unstructured":"Sukhova GK, Williams JK, Libby P (2002) Statins reduce inflammation in atheroma of nonhuman primates Independent of effects on serum cholesterol. Arterioscler Thromb Vasc Biol 22:1452\u20131458. https:\/\/doi.org\/10.1161\/01.atv.0000030360.72503.56","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.phrs.2007.02.001","volume":"55","author":"M Monetti","year":"2007","unstructured":"Monetti M, Canavesi M, Camera M, Parente R, Paoletti R, Tremoli E, Corsini A, Bellosta S (2007) Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoe-deficient mice. Pharmacol Res 55:441\u2013449. https:\/\/doi.org\/10.1016\/j.phrs.2007.02.001","journal-title":"Pharmacol Res"},{"key":"2910_CR25","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1161\/hq0701.092143","volume":"21","author":"M Yoshida","year":"2001","unstructured":"Yoshida M, Sawada T, Ishii H, Gerszten RE, Rosenzweig A, Gimbrone MA Jr, Yasukochi Y, Numano F (2001) Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of rho GTPase-dependent mechanism. Arterioscler Thromb Vasc Biol 21:1165\u20131171. https:\/\/doi.org\/10.1161\/hq0701.092143","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/01.atv.17.2.265","volume":"17","author":"S Colli","year":"1997","unstructured":"Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E (1997) Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 17:265\u2013272. https:\/\/doi.org\/10.1161\/01.atv.17.2.265","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.atv.0000012802.69414.a8","volume":"22","author":"R Baetta","year":"2002","unstructured":"Baetta R, Camera M, Comparato C, Altana C, Ezekowitz MD, Tremoli E (2002) Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering. Arterioscler Thromb Vasc Biol 22:692\u2013698. https:\/\/doi.org\/10.1161\/01.atv.0000012802.69414.a8","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00005344-200106000-00014","volume":"37","author":"S Lopez","year":"2001","unstructured":"Lopez S, Peiretti F, Bonardo B, Deprez-Beauclair P, Laouenan H, Juhan-Vague I, Nalbone G (2001) Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesis in human monocytes\/macrophages. J Cardiovasc Pharmacol 37:762\u2013768. https:\/\/doi.org\/10.1097\/00005344-200106000-00014","journal-title":"J Cardiovasc Pharmacol"},{"key":"2910_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/01.atv.20.2.556","volume":"20","author":"T Bourcier","year":"2000","unstructured":"Bourcier T, Libby P (2000) HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 20:556\u2013562. https:\/\/doi.org\/10.1161\/01.atv.20.2.556","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR30","first-page":"627","volume":"98","author":"GS Guven","year":"2006","unstructured":"Guven GS, Atalar E, Yavuz B, Beyazit Y, Kekilli M, Kilicarslan A, Sahiner L, Oz G, Ozer N, Aksoyek S, Haznedaroglu IC, Sozen T (2006) Simvastatin treatment improves endothelial function and increases fibrinolysis in patients with hypercholestrolemia. J Natl Med Assoc 98:627\u2013630","journal-title":"J Natl Med Assoc"},{"key":"2910_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ijcard.2003.08.003","volume":"95","author":"F Bruni","year":"2004","unstructured":"Bruni F, Pasqui AL, Pastorelli M, Bova G, Di Renzo M, Cercigani M, Leo A, Auteri A, Puccetti L (2004) Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. Int J Cardiol 95:269\u2013274. https:\/\/doi.org\/10.1016\/j.ijcard.2003.08.003","journal-title":"Int J Cardiol"},{"key":"2910_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/00001721-200309000-00010","volume":"14","author":"J Shi","year":"2003","unstructured":"Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D, Mehta JL, Ponnappan U, Lin P, Fink LM, Hauer-Jensen M (2003) Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract Tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis 14:575\u2013585. https:\/\/doi.org\/10.1097\/00001721-200309000-00010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2910_CR33","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.ATV.0000060461.64771.F0","volume":"23","author":"K Masamura","year":"2003","unstructured":"Masamura K, Oida K, Kanehara H, Suzuki J, Horie S, Ishii H, Miyamori I (2003) Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the rho family. Arterioscler Thromb Vasc Biol 23:512\u2013517. https:\/\/doi.org\/10.1161\/01.ATV.0000060461.64771.F0","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1161\/ATVBAHA.109.190884","volume":"29","author":"C Obi","year":"2009","unstructured":"Obi C, Wysokinski W, Karnicki K, Owen WG, McBane RD (2009) Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy. Arterioscler Thromb Vasc Biol 29:1271\u20131276. https:\/\/doi.org\/10.1161\/ATVBAHA.109.190884","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2910_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/09537104.2010.512402","volume":"22","author":"S Matetzky","year":"2011","unstructured":"Matetzky S, Fefer P, Shenkman B, Shechter M, Novikov I, Savion N, Varon D, Hod H (2011) Statins have an early antiplatelet effect in patients with acute Myocardial Infarction. Platelets 22:103\u2013110. https:\/\/doi.org\/10.3109\/09537104.2010.512402","journal-title":"Platelets"},{"key":"2910_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.cir.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129\u20131135. https:\/\/doi.org\/10.1161\/01.cir.97.12.1129","journal-title":"Circulation"},{"key":"2910_CR37","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/01.hyp.37.6.1450","volume":"37","author":"S Wassmann","year":"2001","unstructured":"Wassmann S, Laufs U, B\u00e4umer AT, M\u00fcller K, Ahlbory K, Linz W, Itter G, R\u00f6sen R, B\u00f6hm M, Nickenig G (2001) HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic Hypertension via reduced production of reactive oxygen species. Hypertension 37:1450\u20131457. https:\/\/doi.org\/10.1161\/01.hyp.37.6.1450","journal-title":"Hypertension"},{"key":"2910_CR38","first-page":"73","volume":"48","author":"T Matsuda","year":"1996","unstructured":"Matsuda T (1996) Clinical aspects of DIC\u2013disseminated intravascular coagulation. Pol J Pharmacol 48:73\u201375","journal-title":"Pol J Pharmacol"},{"key":"2910_CR39","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/CCM.0000000000002997","volume":"46","author":"PG Lyons","year":"2018","unstructured":"Lyons PG, Micek ST, Hampton N, Kollef MH (2018) Sepsis-associated coagulopathy severity predicts hospital mortality. Crit Care Med 46:736\u2013742. https:\/\/doi.org\/10.1097\/CCM.0000000000002997","journal-title":"Crit Care Med"},{"key":"2910_CR40","doi-asserted-by":"publisher","first-page":"e27477","DOI":"10.7759\/cureus.27477","volume":"14","author":"D Solanki","year":"2022","unstructured":"Solanki D, Lal D, Sunny A, Han X, Iyanar S, Halder A, Mullangi S, Desai M, Khan U, Theli A, Devani H, Kumar P, Patel AA, Lekkala M (2022) Temporal trends, predictors, and outcomes of disseminated intravascular coagulation in Hospitalizations with Sepsis. Cureus 14:e27477. https:\/\/doi.org\/10.7759\/cureus.27477","journal-title":"Cureus"},{"key":"2910_CR41","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1097\/CCM.0b013e31828cf104","volume":"41","author":"W Alhazzani","year":"2013","unstructured":"Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ (2013) Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care Med 41:2088\u20132098. https:\/\/doi.org\/10.1097\/CCM.0b013e31828cf104","journal-title":"Crit Care Med"},{"issue":"5","key":"2910_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2019","unstructured":"Tang N, Bai H, Chen X, Gong J, Li D, Sun Z (2019) Anticoagulant treatment is associated with decreased mortality in severe coronavirus Disease 2019 patients with coagulopathy. J Thromb Haemost 18(5):1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817","journal-title":"J Thromb Haemost"},{"key":"2910_CR43","doi-asserted-by":"publisher","unstructured":"Asakura H, Ogawa H COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol 113:45\u201357. https:\/\/doi.org\/10.1007\/s12185-020-03029-y","DOI":"10.1007\/s12185-020-03029-y"},{"key":"2910_CR44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/CCM.0000000000000763","volume":"43","author":"R Zarychanski","year":"2015","unstructured":"Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, H\u00e9bert P, Cook DJ, Fergusson DA, Canadian Critical Care Trials Group (2015) The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med 43:511\u2013518. https:\/\/doi.org\/10.1097\/CCM.0000000000000763","journal-title":"Crit Care Med"},{"key":"2910_CR45","doi-asserted-by":"publisher","first-page":"25984","DOI":"10.1038\/srep25984","volume":"6","author":"Y Fan","year":"2016","unstructured":"Fan Y, Jiang M, Gong D, Zou C (2016) Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials. Sci Rep 6:25984. https:\/\/doi.org\/10.1038\/srep25984","journal-title":"Sci Rep"},{"key":"2910_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1055\/s-0039-3402478","volume":"46","author":"G Lippi","year":"2020","unstructured":"Lippi G, Langer F, Favaloro EJ (2020) Direct oral anticoagulants for disseminated intravascular coagulation: an alliterative wordplay or potentially Valuable Therapeutic interventions? Semin Thromb Hemost 46:457\u2013464. https:\/\/doi.org\/10.1055\/s-0039-3402478","journal-title":"Semin Thromb Hemost"},{"key":"2910_CR47","doi-asserted-by":"publisher","first-page":"709155","DOI":"10.3389\/fimmu.2021.709155","volume":"12","author":"H Liang","year":"2021","unstructured":"Liang H, Song H, Zhai R, Song G, Li H, Ding X, Kan Q, Sun T (2021) Corticosteroids for treating Sepsis in adult patients: a systematic review and Meta-analysis. Front Immunol 12:709155. https:\/\/doi.org\/10.3389\/fimmu.2021.709155","journal-title":"Front Immunol"},{"key":"2910_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamacardio.2018","volume":"3","author":"MG Nanna","year":"2018","unstructured":"Nanna MG, Navar AM, Zakroysky P et al (2018) Association of Patient Perceptions of Cardiovascular Risk and beliefs on statin Drugs with racial differences in statin use: insights from the patient and Provider Assessment of lipid Management Registry. JAMA Cardiol 3:739\u2013748. https:\/\/doi.org\/10.1001\/jamacardio.2018","journal-title":"JAMA Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02910-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-023-02910-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-023-02910-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T08:23:46Z","timestamp":1708331026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-023-02910-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["2910"],"URL":"https:\/\/doi.org\/10.1007\/s11239-023-02910-x","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"22 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have indicated they have no potential conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research was supported (in whole or in part) by HCA Healthcare and\/or an HCA Healthcare affiliated entity. The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}